Gestational Trophoblastic Neoplasia
As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease thay only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary. Un...
Gespeichert in:
| Veröffentlicht in: | CA: a cancer journal for clinicians 1981-11, Vol.31 (6), p.322-332 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 332 |
|---|---|
| container_issue | 6 |
| container_start_page | 322 |
| container_title | CA: a cancer journal for clinicians |
| container_volume | 31 |
| creator | Hammond, Charles B Weed, John C., Jr Barnard, David E Tyrey, Lee |
| description | As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease thay only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary. Understanding and utilizing the HCG assay to monitor disease status is vital. With this approach, essentially all of these patients should survive, many to have successful future pregnancies. |
| doi_str_mv | 10.3322/canjclin.31.6.322 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73969658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73969658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3782-c17d53fa81513d2d8d44a01b614f27a5c965749e71f372e7be022f714b26be113</originalsourceid><addsrcrecordid>eNqFkEFLwzAUx4Moc04_gAdBEDwIrXlJmnTHUXQKQy_zHNI0dRlpU5uNsW9vRueunpK8936_PP4I3QJOKSXkWat2rZ1tUwopT2PlDI0hYyRhOafnaIwxFsmU0OwSXYWwxoe3ECM04iTnOGNj9DA3YaM21rfK3S9736186VTYWH3_YXwXr1Zdo4tauWBujucEfb2-LIu3ZPE5fy9mi0RTkZNEg6gyWqscMqAVqfKKMYWh5MBqIlSmpzwTbGoE1FQQI0qDCakFsJLw0gDQCXocvF3vf7ZxL9nYoI1zqjV-G6SgUx4deRyEYVD3PoTe1LLrbaP6vQQsD8HIv2AkBcllrETm7ijflo2pTsQxidjnQ39nndn_L5TFbFYM4qcBXNnv1c72RoZGORe_gUj5NkLmtMUvi69_QA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73969658</pqid></control><display><type>article</type><title>Gestational Trophoblastic Neoplasia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hammond, Charles B ; Weed, John C., Jr ; Barnard, David E ; Tyrey, Lee</creator><creatorcontrib>Hammond, Charles B ; Weed, John C., Jr ; Barnard, David E ; Tyrey, Lee</creatorcontrib><description>As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease thay only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary. Understanding and utilizing the HCG assay to monitor disease status is vital. With this approach, essentially all of these patients should survive, many to have successful future pregnancies.</description><identifier>ISSN: 0007-9235</identifier><identifier>EISSN: 1542-4863</identifier><identifier>DOI: 10.3322/canjclin.31.6.322</identifier><identifier>PMID: 6286054</identifier><language>eng</language><publisher>Bristol: Am Cancer Soc</publisher><subject>Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Chorionic Gonadotropin - analysis ; Dilatation and Curettage ; Female ; Humans ; Hydatidiform Mole - diagnosis ; Hydatidiform Mole - metabolism ; Hydatidiform Mole - therapy ; Pregnancy ; Prognosis ; Trophoblastic Neoplasms - diagnosis ; Trophoblastic Neoplasms - metabolism ; Trophoblastic Neoplasms - therapy ; Ultrasonography ; Uterine Neoplasms - diagnosis ; Uterine Neoplasms - metabolism ; Uterine Neoplasms - therapy</subject><ispartof>CA: a cancer journal for clinicians, 1981-11, Vol.31 (6), p.322-332</ispartof><rights>Copyright © 1981 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3782-c17d53fa81513d2d8d44a01b614f27a5c965749e71f372e7be022f714b26be113</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.3322%2Fcanjclin.31.6.322$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.3322%2Fcanjclin.31.6.322$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6286054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hammond, Charles B</creatorcontrib><creatorcontrib>Weed, John C., Jr</creatorcontrib><creatorcontrib>Barnard, David E</creatorcontrib><creatorcontrib>Tyrey, Lee</creatorcontrib><title>Gestational Trophoblastic Neoplasia</title><title>CA: a cancer journal for clinicians</title><addtitle>CA Cancer J Clin</addtitle><description>As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease thay only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary. Understanding and utilizing the HCG assay to monitor disease status is vital. With this approach, essentially all of these patients should survive, many to have successful future pregnancies.</description><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Chorionic Gonadotropin - analysis</subject><subject>Dilatation and Curettage</subject><subject>Female</subject><subject>Humans</subject><subject>Hydatidiform Mole - diagnosis</subject><subject>Hydatidiform Mole - metabolism</subject><subject>Hydatidiform Mole - therapy</subject><subject>Pregnancy</subject><subject>Prognosis</subject><subject>Trophoblastic Neoplasms - diagnosis</subject><subject>Trophoblastic Neoplasms - metabolism</subject><subject>Trophoblastic Neoplasms - therapy</subject><subject>Ultrasonography</subject><subject>Uterine Neoplasms - diagnosis</subject><subject>Uterine Neoplasms - metabolism</subject><subject>Uterine Neoplasms - therapy</subject><issn>0007-9235</issn><issn>1542-4863</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFLwzAUx4Moc04_gAdBEDwIrXlJmnTHUXQKQy_zHNI0dRlpU5uNsW9vRueunpK8936_PP4I3QJOKSXkWat2rZ1tUwopT2PlDI0hYyRhOafnaIwxFsmU0OwSXYWwxoe3ECM04iTnOGNj9DA3YaM21rfK3S9736186VTYWH3_YXwXr1Zdo4tauWBujucEfb2-LIu3ZPE5fy9mi0RTkZNEg6gyWqscMqAVqfKKMYWh5MBqIlSmpzwTbGoE1FQQI0qDCakFsJLw0gDQCXocvF3vf7ZxL9nYoI1zqjV-G6SgUx4deRyEYVD3PoTe1LLrbaP6vQQsD8HIv2AkBcllrETm7ijflo2pTsQxidjnQ39nndn_L5TFbFYM4qcBXNnv1c72RoZGORe_gUj5NkLmtMUvi69_QA</recordid><startdate>198111</startdate><enddate>198111</enddate><creator>Hammond, Charles B</creator><creator>Weed, John C., Jr</creator><creator>Barnard, David E</creator><creator>Tyrey, Lee</creator><general>Am Cancer Soc</general><general>John Wiley & Sons, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198111</creationdate><title>Gestational Trophoblastic Neoplasia</title><author>Hammond, Charles B ; Weed, John C., Jr ; Barnard, David E ; Tyrey, Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3782-c17d53fa81513d2d8d44a01b614f27a5c965749e71f372e7be022f714b26be113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Chorionic Gonadotropin - analysis</topic><topic>Dilatation and Curettage</topic><topic>Female</topic><topic>Humans</topic><topic>Hydatidiform Mole - diagnosis</topic><topic>Hydatidiform Mole - metabolism</topic><topic>Hydatidiform Mole - therapy</topic><topic>Pregnancy</topic><topic>Prognosis</topic><topic>Trophoblastic Neoplasms - diagnosis</topic><topic>Trophoblastic Neoplasms - metabolism</topic><topic>Trophoblastic Neoplasms - therapy</topic><topic>Ultrasonography</topic><topic>Uterine Neoplasms - diagnosis</topic><topic>Uterine Neoplasms - metabolism</topic><topic>Uterine Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammond, Charles B</creatorcontrib><creatorcontrib>Weed, John C., Jr</creatorcontrib><creatorcontrib>Barnard, David E</creatorcontrib><creatorcontrib>Tyrey, Lee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>CA: a cancer journal for clinicians</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammond, Charles B</au><au>Weed, John C., Jr</au><au>Barnard, David E</au><au>Tyrey, Lee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gestational Trophoblastic Neoplasia</atitle><jtitle>CA: a cancer journal for clinicians</jtitle><addtitle>CA Cancer J Clin</addtitle><date>1981-11</date><risdate>1981</risdate><volume>31</volume><issue>6</issue><spage>322</spage><epage>332</epage><pages>322-332</pages><issn>0007-9235</issn><eissn>1542-4863</eissn><abstract>As a result of modern diagnostic and therapeutic techniques, nearly 100 percent of patients with GTN can be cured of a disease thay only a few years ago had a high death rate. To achieve this, skillful mixing of chemotherapy, surgery, and irradiation, as well as supportive therapy, are necessary. Understanding and utilizing the HCG assay to monitor disease status is vital. With this approach, essentially all of these patients should survive, many to have successful future pregnancies.</abstract><cop>Bristol</cop><pub>Am Cancer Soc</pub><pmid>6286054</pmid><doi>10.3322/canjclin.31.6.322</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-9235 |
| ispartof | CA: a cancer journal for clinicians, 1981-11, Vol.31 (6), p.322-332 |
| issn | 0007-9235 1542-4863 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73969658 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Chorionic Gonadotropin - analysis Dilatation and Curettage Female Humans Hydatidiform Mole - diagnosis Hydatidiform Mole - metabolism Hydatidiform Mole - therapy Pregnancy Prognosis Trophoblastic Neoplasms - diagnosis Trophoblastic Neoplasms - metabolism Trophoblastic Neoplasms - therapy Ultrasonography Uterine Neoplasms - diagnosis Uterine Neoplasms - metabolism Uterine Neoplasms - therapy |
| title | Gestational Trophoblastic Neoplasia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A33%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gestational%20Trophoblastic%20Neoplasia&rft.jtitle=CA:%20a%20cancer%20journal%20for%20clinicians&rft.au=Hammond,%20Charles%20B&rft.date=1981-11&rft.volume=31&rft.issue=6&rft.spage=322&rft.epage=332&rft.pages=322-332&rft.issn=0007-9235&rft.eissn=1542-4863&rft_id=info:doi/10.3322/canjclin.31.6.322&rft_dat=%3Cproquest_cross%3E73969658%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73969658&rft_id=info:pmid/6286054&rfr_iscdi=true |